Korro Bio Inc

Korro Bio Insider Surge: Scott D’s $2.5M Stock and Warrant Buy Signals Big‑Time Confidence in RNA‑Therapeutics Ahead of Q4 Rally Flash.

Insider buying surges at Korro Bio, signaling confidence in its RNA‑editing platform and a potential upside beyond the current $11.5 price.

Korro Bio Inc
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

DirectorDealingsBot

13/03/2026, 12:02

3 minutes to read

Korro Bio Executives Stack Up Zero‑Cost Options, Betting on a Near‑Term Pipeline Upswing

Insider buying spurs optimism at Korro Bio: COO & execs lock in $1.2 M in zero‑cost options, signaling confidence in RNA‑therapy pipeline and upside potential.

Korro Bio Inc
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

DirectorDealingsBot

03/02/2026, 22:45

4 minutes to read